Medical marijuana entrepreneur announces research, labor agreements

Warning message

The subscription service is currently unavailable. Please try again later.

As the high-stakes competition to win one of five coveted licenses to run a medical marijuana operation in New York gets down to the wire, an organization that proposes to grow and extract the drug in Glenville shared news on Tuesday that appeared designed to raise its local profile.

Fiorello Pharmaceuticals announced that, if selected as a medical marijuana operator, it would distribute $5 million in research grants statewide, including $1 million to Capital Region scientists, over five years. Research on marijuana's effects has been scant, in part due to federal restrictions.

The fledgling company has also signed a project labor agreement with the Greater Capital Region Building & Construction Trades Council, AFL-CIO and its affiliates. The agreement applies to renovation and construction of Fiorello facilities statewide. In addition to its plans to invest $10 million in a 120,000-square-foot facility at the Glenville Business and Technology Park,...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://www.timesunion.com/news/article/Medical-marijuana-entrepreneur-announces-6371715.php